Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
Update: 2025-12-23
Description
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means for patients, clinicians, and oncology practice.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
